Apollo, Kohlberg and Montagu are pursuing surgical equipment providers, and a radiopharma boom aided Trilantic North America’s $945m exit from SOFIE Biosciences, according to PE Hub.
Surgical equipment providers
PE Hub’s item discusses the influence of “barriers to entry” in the healthcare market for surgical equipment providers, according to PE Hub.
The report links that theme to private equity firms that already have a “sizeable presence in a sector,” according to PE Hub.
Radiopharmaceuticals and SOFIE Biosciences
The same PE Hub report describes how a radiopharma boom aided Trilantic North America’s $945m SOFIE Biosciences exit, according to PE Hub.
What PE Hub published
The story is filed under “Healthcare” and lists “North America” in its tagging, according to PE Hub.
The post is authored by John R Fischer and was published “4 hours ago” at the time shown on PE Hub, according to PE Hub.
PE Hub labels the item “Commentary” and “PE Hub Wire,” according to PE Hub.
Context
Private equity is widely known to target healthcare subsectors with defensible competitive dynamics such as regulatory and technical barriers to entry.
Radiopharmaceuticals are widely known as a segment of healthcare linked to diagnostic and therapeutic uses of radioisotopes.
